{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:25:05Z","timestamp":1784093105354,"version":"3.55.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,28]]},"DOI":"10.7759\/cureus.74694","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T03:36:12Z","timestamp":1732851372000},"source":"Crossref","is-referenced-by-count":1,"title":["Tofacitinib in Leprosy: A Novel Therapeutic Approach in Chronic Recalcitrant Type II Reactions"],"prefix":"10.7759","author":[{"given":"Benaka","family":"Suresh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja R","family":"Reshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayalekshmi","family":"Jaipal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gajanan A","family":"Pise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruthi S","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Manohar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.879527","article-title":"Case report: A case series of immunobiological therapy (anti-TNF-\u03b1) for patients with erythema nodosum leprosum","volume":"9","author":"Mendes AF","year":"2022","unstructured":"Mendes AF, Gomes CM, Kurizky PS, Ianhez M. Case report: A case series of immunobiological therapy (anti-TNF-\u03b1) for patients with erythema nodosum leprosum. Front Med (Lausanne). 2022, 9:879527. 10.3389\/fmed.2022.879527","journal-title":"Front Med (Lausanne)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00233","article-title":"A systematic review of immunological studies of erythema nodosum leprosum","volume":"8","author":"Polycarpou A","year":"2017","unstructured":"Polycarpou A, Walker SL, Lockwood DN. A systematic review of immunological studies of erythema nodosum leprosum. Front Immunol. 2017, 8:233. 10.3389\/fimmu.2017.00233","journal-title":"Front Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5178.185495","article-title":"Quality of life in patients with erythema nodosum leprosum in Kuala Lumpur, Malaysia","volume":"7","author":"Yap FB","year":"2016","unstructured":"Yap FB, Kiung ST, Yap JB. Quality of life in patients with erythema nodosum leprosum in Kuala Lumpur, Malaysia. Indian Dermatol Online J. 2016, 7:255-8. 10.4103\/2229-5178.185495","journal-title":"Indian Dermatol Online J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2018.1512404","article-title":"Tofacitinib for the treatment of psoriasis and psoriatic arthritis","volume":"14","author":"Berekmeri A","year":"2018","unstructured":"Berekmeri A, Mahmood F, Wittmann M, Helliwell P. Tofacitinib for the treatment of psoriasis and psoriatic arthritis. Expert Rev Clin Immunol. 2018, 14:719-30. 10.1080\/1744666X.2018.1512404","journal-title":"Expert Rev Clin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1086\/650318","article-title":"Integrated pathways for neutrophil recruitment and inflammation in leprosy","volume":"201","author":"Lee DJ","year":"2010","unstructured":"Lee DJ, Li H, Ochoa MT, et al.. Integrated pathways for neutrophil recruitment and inflammation in leprosy. J Infect Dis. 2010, 201:558-69. 10.1086\/650318","journal-title":"J Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2006.11.025","article-title":"Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease","volume":"44","author":"O'Sullivan LA","year":"2007","unstructured":"O'Sullivan LA, Liongue C, Lewis RS, Stephenson SE, Ward AC. Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease. Mol Immunol. 2007, 44:2497-506. 10.1016\/j.molimm.2006.11.025","journal-title":"Mol Immunol"},{"key":"ref7","article-title":"The effect of spinal manipulation on pain and prostaglandin levels in women with primary dysmenorrhea","volume":"15","author":"Kokjohn K","year":"1992","unstructured":"Kokjohn K, Schmid DM, Triano JJ, Brennan PC. The effect of spinal manipulation on pain and prostaglandin levels in women with primary dysmenorrhea. J Manipulative Physiol Ther. 1992, 15:279-85.","journal-title":"J Manipulative Physiol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.4.1441-1446.1992","article-title":"Tumor necrosis factor production in patients with leprosy","volume":"60","author":"Barnes PF","year":"1992","unstructured":"Barnes PF, Chatterjee D, Brennan PJ, Rea TH, Modlin RL. Tumor necrosis factor production in patients with leprosy. Infect Immun. 1992, 60:1441-6. 10.1128\/iai.60.4.1441-1446.1992","journal-title":"Infect Immun"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-9-75","article-title":"Potential plasma markers of type 1 and type 2 leprosy reactions: a preliminary report","volume":"9","author":"Stefani MM","year":"2009","unstructured":"Stefani MM, Guerra JG, Sousa AL, Costa MB, Oliveira ML, Martelli CT, Scollard DM. Potential plasma markers of type 1 and type 2 leprosy reactions: a preliminary report. BMC Infect Dis. 2009, 9:75. 10.1186\/1471-2334-9-75","journal-title":"BMC Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003668","article-title":"Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550)","volume":"186","author":"Ghoreschi K","year":"2011","unstructured":"Ghoreschi K, Jesson MI, Li X, et al.. Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550). J Immunol. 2011, 186:4234-43. 10.4049\/jimmunol.1003668","journal-title":"J Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1084\/jem.175.6.1729","article-title":"Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients","volume":"175","author":"Sampaio EP","year":"1992","unstructured":"Sampaio EP, Moreira AL, Sarno EN, Malta AM, Kaplan G. Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients. J Exp Med. 1992, 175:1729-37. 10.1084\/jem.175.6.1729","journal-title":"J Exp Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/art.34329","article-title":"The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-\u03b3 and interleukin-17 production by human CD4+ T cells","volume":"64","author":"Maeshima K","year":"2012","unstructured":"Maeshima K, Yamaoka K, Kubo S, et al.. The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-\u03b3 and interleukin-17 production by human CD4+ T cells. Arthritis Rheum. 2012, 64:1790-8. 10.1002\/art.34329","journal-title":"Arthritis Rheum"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01149","article-title":"New insight into the pathogenesis of erythema nodosum leprosum: the role of activated memory T-cells","volume":"8","author":"Negera E","year":"2017","unstructured":"Negera E, Bobosha K, Walker SL, et al.. New insight into the pathogenesis of erythema nodosum leprosum: the role of activated memory T-cells. Front Immunol. 2017, 8:1149. 10.3389\/fimmu.2017.01149","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/317732-tofacitinib-in-leprosy-a-novel-therapeutic-approach-in-chronic-recalcitrant-type-ii-reactions","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T03:36:15Z","timestamp":1732851375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/317732-tofacitinib-in-leprosy-a-novel-therapeutic-approach-in-chronic-recalcitrant-type-ii-reactions"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.74694","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,28]]}}}